# Karyopharm Therapeutics Inc.: Form 8-K, filed Feb 24, 2025

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: 8-K
- Filed: 2025-02-24
- Accepted by EDGAR: Feb 24, 2025, 16:16 ET
- Period: 2025-02-24
- Accession: 0000950170-25-025640
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000095017025025640/kpti-20250224.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000095017025025640/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000095017025025640/kpti-20250224.htm

Filed Feb 24, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-025640. Last ingested by Listed: Nov 2, 2026, 09:22 ET. No prices; not investment advice.